Refine your search
Collections
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Shukla, Karunakar
- Antidiabetic Activity of Psidium guajava (Guava) Leaves Extract
Abstract Views :161 |
PDF Views:0
Authors
Affiliations
1 Mahakal Institute of Pharmaceutical Studies, Ujjain (M.P.) 456664, IN
2 Vivekanand College of Pharmacy, Indore (M.P.), IN
1 Mahakal Institute of Pharmaceutical Studies, Ujjain (M.P.) 456664, IN
2 Vivekanand College of Pharmacy, Indore (M.P.), IN
Source
Research Journal of Science and Technology, Vol 1, No 1 (2009), Pagination: 13-15Abstract
Psidium guajava leaves extracts were investigated for hypoglycemic activity. Aqueous extract and ethanolic extract of leaves were prepared and screened for hypoglycemic activity. Psidium guajava therapy not only produces blood glucose homeostasis but also reversed metabolic and pathologic changes that took place in pancreatic islets.β-cell secretary activity resumed near normal as evidenced electron microscopic studies. In diabetic albino rats, mean percentage reduction in blood glucose level was found to be 18.88 % and 9.19±% for ethanolic and aqueous extracts respectively. The effect was initiated from first day and increase simultaneously up to thirteenth day. The hypoglycemic effect of ethanolic extract was better compared to same dose of aqueous extract. Blood glucose monitoring and electron-microscopic studies proving that Psidium guajava manifests its beneficial activity through β-cell rejuvenation, regeneration and stimulation.Keywords
Psidium guajava, Hypoglycemic Activity, Ethanolic Extract, Aqoeus Extract.- Bioassay:An Uncomplicated Methodologies for Ensure Safety of Traditional formulations
Abstract Views :152 |
PDF Views:0
Authors
Affiliations
1 Mahakal Institute of Pharmaceutical Studies, Ujjain (M.P.) 456664, IN
1 Mahakal Institute of Pharmaceutical Studies, Ujjain (M.P.) 456664, IN
Source
Research Journal of Pharmacognosy and Phytochemistry, Vol 1, No 1 (2009), Pagination: 1-4Abstract
In the recent years' there has been a great demand for the plant derived traditional formulations in the developed countries. These formulations are increasingly being required as medicinal products, nutraceuticals, and cosmetics. India has one of the 12th mega biodiversities in the world and having great assets of traditional systems of medicines (Ayurveda, Siddha and Unani). One of the major region for the India's inadequate execution is that our products are not backed by rigorous scientific studies to established their safity, efficacy, and standards. For the purpose of develops safety, efficacy, and standards, the importance of standardization of Traditional formulation and crude drugs is now well understood by the consumers as well as the industry. Standardization helps in effective quality control during commercial production of Traditional formulations. During the last few years' emphasis has been laid on chemical methods of standardization, based on physical chemical assay, chromatographic analysis and various spectroscopic techniques. Most of these are qualitative methods though many Traditional formulation and crude plant material have been standardized quantitavely using HPLC, HPTLC, GC and these methods are used as an effective quality control perameters. In such cases chemical marker have been isolated and characterized, in several plant materials spectroscopic method of standardization have also been found to be usefull. However, marker compound based standardization has not been effective since these markers are not biologically active constituents in the most of the cases. All the methods are accounts for a single chemical entity or a group of chemical compounds, but in many plants the activity may be attributed to different type of compounds that act synergistically to show the biological activity. There fore the standardization by chemical methods, although used widely, may not prove to be a complete way of standardization for Traditional formulation and further needs biological standardization.- Evaluation of Toxicity and Antidiabetic Activity of Ethanolic Extract of Flowers of Moringa Oleifera Against Dexamethasone Induced Hyperglycemia in Albino Wistar Rats
Abstract Views :88 |
PDF Views:0
Authors
Affiliations
1 College of Pharmacy, Dr. A.P.J. Abdul Kalam University, Indore (M.P.), IN
1 College of Pharmacy, Dr. A.P.J. Abdul Kalam University, Indore (M.P.), IN
Source
Research Journal of Pharmacy and Technology, Vol 15, No 2 (2022), Pagination: 517-524Abstract
Diabetes is a defect in the ability of the body to convert glucose (sugar) to energy. Glucose is the main source of energy in our body. When food is digested it is metabolized into fats, proteins, or carbohydrates. Glucose is then transferred to the blood and is used by the cells for energy production. To investigate the antidiabetic effect ethanolic extracts of flowers of Moringa oleifera against dexamethasone-induced insulin resistance in wistar albino rats. To study the antidiabetic effect, flowers of Moringa oleifera were collected and authenticated, extracted and investigated for acute toxicity and dexamethasone induced hyperglcemia. The animals treated with EEMOF at a dose of 100mg/kg and 200mg/kg prevented the development of hyperglycemia, hypercholesteremia and hypertriglyceridemia in dexamethasone induced insulin resistance models. Oral administration of Moringa oleifera 100mg/kg and 200mg/kg reduces serum glucose, triglyceride, total cholesterols and LDL concentration and improve the concentration of HDL in dexamethasone administered rats. The lignin Moringa oleifera showed significant anti-diabetic effect in rats after oral administration. The present study demonstrated that Moringa oleifera could be useful in Management of diabetes associated with abnormalities in lipid profiles. Further study need to isolate, identify the active compounds and find out the possible mechanism of actions.Keywords
Moringa oleifera, Dexamethasone, Hyperglycemia, Ethanolic Extract.References
- Gisela Wilcox. Insulin and Insulin Resistance. Clin Biochem Rev. 2005 May; 26(2): 19– 39.
- Dongare, S. S., Maske, A. P., Patil, S. M., Umbare, R. P., and Mate, G. S. Antidiabetic Activity of Marsilea quadrifolia linn in alloxan-diabetic rats. Research Journal of Pharmacognosy and Phytochemistry. 2009; 1(1): 15-17.
- Radhika, K., Kumaravel, B., Thamizhiniyan, V., and Subramanian, S. Biochemical evaluation of antidiabetic activity of Piper betel leaves extract in alloxan-induced diabetic rats. Asian Journal of Research in Chemistry. 2013; 6(1): 76-82.
- Macharla, S. P., Goli, V., and Nath, A. R. Antidiabetic Activity of Bambusa arundinaceae Root Extracts on Alloxan Induced Diabetic Rats. Asian Journal of Research in Pharmaceutical Science. 2012; 2(2): 73-75.
- World Health Organization. Obesity: Preventing and Managing the Global Epidemic Report of a WHO Consultation Technical Report Series. World Health Organization, Geneva 2000.
- Vengal Rao, P., Krishnamurthy, P. T., Dahapal, S. P., and Chinthamaneni, P. K. An updated review on “Miracle tree”: Moringa oleifera. Research Journal of Pharmacognosy and Phytochemistry. 2018; 10(1): 101-108.
- Patil, S. R., Patil, M. B., Kumar, R., and Paschapur, M. S. Effect of Ethanolic Extract of Borassus flabellifer L. Male Flowers (Inflorescences) on Chemically Induced Inflammation in Wistar Rats. Research Journal of Pharmacognosy and Phytochemistry. 2009; 1(1): 59-63.
- Ramachandran, C., Peter, K. V., and Gopalakrishnan, P. K. Drumstick (Moringa oleifera): a multipurpose Indian vegetable. Economic Botany. 2009; 276-283.
- Vaishnav, A., Chandy, A., Jhade, D., and Rai, S. Pharmacognostical and Preliminary Phytochemical Studies on Moringa olifera Leaves. Research Journal of Pharmacognosy and Phytochemistry. 2011; 3(6): 272-274.
- Pasha, S., Khaleel, M., and Som, S. Evaluation of Adaptogenic Activity of Moringa oleifera Lam. Research Journal of Pharmacology and Pharmacodynamics. 2010; 2(3): 243-247.
- Rastogi, T., Bhutda, V., Moon, K., Aswar, P. B., and Khadabadi, S. S. Comparative studies on anthelmintic activity of Moringa oleifera and Vitex negundo. Asian Journal of Research in Chemistry. 2009; 2(2): 181-182.
- Desai, S. A., Darji, D., and Makwana, M. In-Vitro Anti Bacterial Activity of Water Extract of Moringa oleifera Leaf Stalk. Research Journal of Pharmacognosy and Phytochemistry. 2011; 3(6): 297-299.
- Pasha, S., Khaleel, M., and Som, S. Evaluation of Adaptogenic Activity of Moringa oleifera Lam. Research Journal of Pharmacology and Pharmacodynamics. 2010; 2(3): 243-247.
- Manjula, B., Hunasagi, R., and Shivalinge, G. K. Anti-Obesity Activity of Ethanolic Extract of Moringa oleifera Seeds In Experimental Animals. Research Journal of Pharmacology and Pharmacodynamics. 2011; 3(6): 318-328.
- Pasieka, A. M., and Rafacho, A. Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence. Metabolites. 2016; 6(3): 24.
- Geer, E. B., Islam, J., and Buettner, C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinology and Metabolism Clinics. 2014; 43(1): 75-102.
- Rosenthaler, L. Chemical investigations of Plants. G. Bell and Sons, London. 1930; 23-29: 119-132.
- Kokate C.K., Purohit A.P., and Gokhale S.B. Pharmacognosy; 23 ed., Nirali prakashan: 2006: pp 493-497.
- Kokate, C. K. Practical Pharmacognosy. Vallabh Prakashan, New Delhi, 4, 1994: 110-111.
- OCDE 423, 2001: OECD guideline for testing of chemicals. Acute Oral Toxicity, Pg. 01-14.
- OECD, 2008. Guideline for the testing of chemicals. Repeated dose 28-day oral toxicity study in rodents (407). 3rd October 2008.
- Bain, B. J., Lewis, S. M., and Bates, I. Basic haematological techniques. Dacie and Lewis Practical Haematology. 2006; 4: 19-46.
- Karmakar, R., Bhattacharya, R., and Chatterjee, M. Biochemical, haematological and histopathological study in relation to time-related cadmium-induced hepatotoxicity in mice. Biometals. 2000; 13(3): 231-239.
- Development and Evaluation of Transdermal patches of Piperine hydrochloride
Abstract Views :77 |
PDF Views:0
Authors
Affiliations
1 College of Pharmacy, Dr. APJ Abdul Kalam University, Indore, M.P., IN
2 Ahinsa Institute of Pharmacy, Dondaicha., IN
1 College of Pharmacy, Dr. APJ Abdul Kalam University, Indore, M.P., IN
2 Ahinsa Institute of Pharmacy, Dondaicha., IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 14, No 2 (2022), Pagination: 133-138Abstract
The fundamentals οf a successful pharmaceutical fοrmulatiοn depend οn the delivery οf the medicament tο the target site at therapeutically relevant level, with negligible οr minimum discοmfοrt and side effects tο the patient. Low dose maintenance therapy of Piperine HCl has the capability to reduce potential side effects and improved patient compliance which are more common with conventional drug delivery. The developed formulation of Piperine HCl is expected to improve the patient compliance, form better dosage regimen and provide maintenance therapy to patients suffering from inflammation and allergy. These promising results showed the feasibility of delivering Piperine HCl through transdermal matrix patch. The developed transdermal patches ofPiperine HCl may prove to be a better alternative to conventional dosage forms in allergy as revealed by the resultsKeywords
Piperine HCl, Transdermal patches, FT-IR spectrοscοpy, UV absοrptiοn and Skin.References
- Jain N.K. (1997). Controlled and novel drug delivery, first edition, CBS Publisher and Distributors New Delhi.
- Chien Y.W. (1992). Novel drug delivery systems, drugs and the Pharmaceutical Sciences, Vol.50, Marcel Dekkar, New York, NY;797.
- Guy R.H. (1996). Current status and future prospects of transdermal drug delivery, Pharm Res., 13, 1765-1769.
- Bagyalakshmi J., Vamsikrishna R.P., Manavalan R., Ravi T.K. and Manna P.K. (2007). Formulation development and in vitro and in vivo evaluation of membrane-moderated transdermal systems of ampicillin sodium in ethanol: pH 4.7 buffer solvent system. AAPS PharmSciTech, 8(1), E50-E55.
- Shaila L., Pandey S and Udupa N. (2006). Design and evaluation of matrix controlled Transdermal drug delivery system of nicitin suitable for use in smoking cessation. Indian Journ. Pharm. Science; 68: 179-184.
- Bernar B. and John V.A. (1994). Pharmacokinetic characterization of Transdermal delivery systems. Jour.Clinical pharmacokinetics, 26(2): 1`21-34.
- Tsai J.C, Guy R.H, Thornfeldt C.R, Gao W.N, Feingold K.R and Elias P.M. (1998). Metabolic Approaches to Enhance Transdermal drug delivery”, Jour.Pharm. Sci.,85;643-648.
- Williams A.C and Barry B. W. (2004). Penetration Enhancers, Adv. Drug delivery ststems, Rev, 56:603-618.
- Pellet M., Raghavan S.L, Hadgraft J and Davis A.F. (2003). The application of supersaturated systems to percutaneous drug delivery” In: Guy R.H. andHadgraft J. Transdermal drug delivery, Marcel Dekkar Inc., New York, 2003, pp, 305-326.
- Loyd V. Allen Jr, Nicholas G. Popovich and Howard C. Ansel (2005). Pharmaceutical dosage forms and drug delivery systems, eighth edition, Wolter Kluwer Publishers, New Delhi.
- Nachum Z., Shupak A., Gordon C.R. (2006). Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics, 45 (6): 543–66.
- Alexander, A., Dwivedi, S., Ajazuddin, Giri, T. K., Saraf, S. and Tripathi, D. K. (2012). Approaches for breaking the barriers of drug permeation through transdermal drug delivery. Journal of Controlled Release, 164(1), 26-40.
- Asbill, C. S. and Michniak, B. B. (2000). Percutaneous penetration enhancers: Local versus transdermal activity. Pharmaceutical Science and Technology Today, 3(1), 36-41.
- Babu, R. J. and Pandit, J. K. (2005). Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. International Journal of Pharmaceutics, 288(2), 325-334.
- Barrett, C. W. (1969). Skin penetration. Journal of Society of Cosmetic Chemists, 487-499.
- Barry, B. W. (2002). Drug delivery routes in skin: A novel approach. Advanced Drug Delivery Reviews, 54, S31-S40.
- Barry, B. W. (2007). Transdermal drug delivery In: Aulton, M. E. (Ed). Pharmaceutics: The design and manufacturing of medicines. 3rd Edition. Churchill Livingstone, London, 2007, 565-587.
- Benson, H. (2005). Transdermal drug delivery: Penetration enhancement techniques. Current Drug Delivery, 2(1), 23-33.
- Brown, M. B. (2006). Dermal and transdermal drug delivery systems: Current and future prospects. Drug Delivery, 13:175-187.
- Chen, Y., Quan, P., Liu, X., Wang, M. and Fang, L. (2014). Novel chemical permeation enhancers for transdermal drug delivery. Asian Journal of Pharmaceutical Sciences, 9(2), 51-64.
- Chien, Y. W. (1992). Transdermal drug delivery and delivery systems. In: Novel drug delivery systems. Marcel Dekker, Inc., New York, 301-380.
- Degim, I. T. (2006). New tools and approaches for predicting skin permeability. Drug Discovery Today, 11(12), 517-523.
- Dhiman, S., Singh, T. G. and Rehni, A. K. (2011). Transdermal patches: A recent approach to new drug delivery system. International Journal of Pharmacy and Pharmaceutical Sciences, 3(5), 26-34.
- Guy, R. H. and Hadgraft, J. (1987). The effect of penetration enhancers on the kinetics of percutaneous absorption. Journal of Controlled Release, 5(1), 43-51.
- Consumer Reports (2013), Using Antihistamines to Treat Allergies, Hay Fever, & Hives - Comparing Effectiveness, Safety, and Price (PDF), Yonkers, New York: Consumer Reports.
- Panula P, Chazot PL, Cowart M, et al. (2015). International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol. Rev. 67 (3): 601–55.
- Leurs R, Church MK, Taglialatela M (2002). H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clinical and Experimental Allergy. 32 (4): 489–98.
- Norrby K (1995). Evidence of a dual role of endogenous histamine in angiogenesis. Int J Exp Pathol. 76 (2): 87–92.
- Monroe EW, Daly AF, Shalhoub RF (1997). "Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines". The Journal of Allergy and Clinical Immunology. 99 (2): S798– 806.
- Terland, O.; Flatmark, T. (1999). "Drug-induced parkinsonism: Cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles". Neuropharmacology. 38 (6): 879–88.